Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2003-5-21
pubmed:abstractText
Recently human cartilage gp-39 (HC gp-39) was identified as a candidate autoantigen in rheumatoid arthritis (RA). To further investigate the relevance of this Ag in RA, we have generated a set of five mAbs to a combination epitope of complexes of HC gp-39(263-275) and the RA-associated DR alpha beta 1*0401 HLA class II molecules. FACS studies revealed that these mAb recognize specific complexes on homozygous DR alpha beta 1*0401-positive B lymphoblastoid cells pulsed with HC gp-39(263-275). The best mAb, 12A, was further characterized using a set of irrelevant DR alpha beta 1*0401-binding peptides and truncated/elongated versions of HC gp-39(263-275) itself. The minimal epitope recognized in combination with DR alpha beta 1*0401 was HC gp-39(263-273). Peptides not encompassing HC gp-39(263-273) were not recognized. Three of five mAb were able to inhibit (up to 90%) the response of HC gp-39(263-275)-specific DR alpha beta 1*0401-restricted T cell hybridomas to peptide-pulsed APC or purified complexes. Using mAb 12A, we have been able to identify and localize dendritic cells that present DR alpha beta 1*0401/HC gp-39(263-275) complexes in synovial tissue of DR alpha beta 1*0401-positive RA patients, indicating local presentation of the HC gp-39(263-275) epitope in the inflamed target tissue by professional APC. These data support a role of HC gp-39 in the local autoimmune response that leads to chronic inflammation and joint destruction.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
170
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5719-27
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12759455-Adipokines, pubmed-meshheading:12759455-Adult, pubmed-meshheading:12759455-Aged, pubmed-meshheading:12759455-Aged, 80 and over, pubmed-meshheading:12759455-Animals, pubmed-meshheading:12759455-Antibodies, Monoclonal, pubmed-meshheading:12759455-Antibody Specificity, pubmed-meshheading:12759455-Antigen Presentation, pubmed-meshheading:12759455-Antigen-Presenting Cells, pubmed-meshheading:12759455-Arthritis, Rheumatoid, pubmed-meshheading:12759455-Autoantigens, pubmed-meshheading:12759455-B-Lymphocyte Subsets, pubmed-meshheading:12759455-Cell Line, Transformed, pubmed-meshheading:12759455-Epitopes, pubmed-meshheading:12759455-Female, pubmed-meshheading:12759455-Glycoproteins, pubmed-meshheading:12759455-HLA-DR Antigens, pubmed-meshheading:12759455-HLA-DRB1 Chains, pubmed-meshheading:12759455-Humans, pubmed-meshheading:12759455-Hybridomas, pubmed-meshheading:12759455-Immunosuppressive Agents, pubmed-meshheading:12759455-Lectins, pubmed-meshheading:12759455-Lymphocyte Activation, pubmed-meshheading:12759455-Mice, pubmed-meshheading:12759455-Mice, Inbred BALB C, pubmed-meshheading:12759455-Middle Aged, pubmed-meshheading:12759455-Peptide Fragments, pubmed-meshheading:12759455-Synovial Membrane
pubmed:year
2003
pubmed:articleTitle
Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies.
pubmed:affiliation
Department of Pharmacology, N. V. Organon, Oss, The Netherlands. peter.steembakkers@organon.com
pubmed:publicationType
Journal Article